Showing results (1-10 of 194) with videos related to
Sort By:
Pageof 20
Clinical and Experimental Nephrology|June 2, 2011
Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenonEiji KusanoCardiovascular & Hematological Agents in Medicinal Chemistry|July 26, 2012
The effects of direct renin inhibitor, aliskiren, on arterial hypertension, chronic kidney disease and cardiovascular disease: optimal pharmacotherapyYoshiyuki Morishita, Eiji KusanoCardiovascular & Hematological Agents in Medicinal Chemistry|October 26, 2011
The blockade of renin-angiotensin-aldosterone system in hemodialysis patients to control hypertension and prevent cardiovascular disease: optimal pharmacotherapyYoshiyuki Morishita, Eiji KusanoClinical Calcium|June 6, 2006
[Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement and clinical role of OPG]Nobuhiro Sasaki, Eiji KusanoNephro-Urology Monthly|April 12, 2013
Direct Renin inhibitor: aliskiren in chronic kidney diseaseYoshiyuki Morishita, Eiji KusanoJournal of Hypertension|November 5, 2005
Mechanisms for nongenomic and genomic effects of aldosterone on Na+/H+ exchange in vascular smooth muscle cellsYukio Miyata, Shigeaki Muto, Eiji KusanoClinical Calcium|January 8, 2008
[Basic and clinical aspects of calcimimetics. Effect of direct injection therapy in the expression of calcium-sensing receptor in parathyroid cell]Kazuhiro Shiizaki, Ryoko Tozawa, Eiji KusanoClinical and Experimental Nephrology|November 1, 2011
Claudins and renal salt transportShigeaki Muto, Mikio Furuse, Eiji KusanoThe Open Cardiovascular Medicine Journal|March 11, 2014
Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing HemodialysisYoshiyuki Morishita, Eiji Kusano, Daisuke NagataOrganogenesis|June 13, 2009
Low ambient o(2) enhances ureteric bud branching in vitroTetsu Akimoto, Marc R Hammerman, Eiji KusanoPageof 20